2023
Differences in clinical features and gut microbiota between individuals with methamphetamine casual use and methamphetamine use disorder
He L, Yang B, Ma Y, Wen L, Liu F, Zhang X, Liu T. Differences in clinical features and gut microbiota between individuals with methamphetamine casual use and methamphetamine use disorder. Frontiers In Cellular And Infection Microbiology 2023, 13: 1103919. PMID: 36909722, PMCID: PMC9996337, DOI: 10.3389/fcimb.2023.1103919.Peer-Reviewed Original ResearchConceptsMA use disorderClinical featuresGut microbiotaWithdrawal symptomsMA usersEnterotype 2Use disordersGM diversityBody mass indexMethamphetamine use disorderSemi-Structured AssessmentMass indexNeuropsychiatric symptomsHigh incidenceDiagnostic criteriaDifferential microbesDistinct enterotypesDrug dependenceGM differencesSymptomsClinical traitsPerformed network analysisStrong cravingsFecal samplesFurther studies
2020
Gut dysbiosis associated with the rats' responses in methamphetamine‐induced conditioned place preference
Yang C, Fu X, Hao W, Xiang X, Liu T, Yang B, Zhang X. Gut dysbiosis associated with the rats' responses in methamphetamine‐induced conditioned place preference. Addiction Biology 2020, 26: e12975. PMID: 33094505, DOI: 10.1111/adb.12975.Peer-Reviewed Original ResearchConceptsMA use disorderGut microbiota compositionGut dysbiosisUse disordersGut microbiotaCPP scoresMicrobiota compositionHigher CPP scoresSusceptible riskRibosomal RNA sequencingCPP trainingRat modelSame doseDrug effectsPlace preferencePotent stimulantDysbiosisRats' responsesImportant modulatorCumulative evidenceRatsLow CPPMethamphetamineDisordersCPP